HIGHLIGHTS
- who: Zhong-Guo Zhou from the Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China, Collaborative Innovation Center have published the paper: Anti-programmed Cell Death Protein-1 Therapy in Intrahepatic Cholangiocarcinoma Induced Type 1 Diabetes: A Case Report and Literature Review, in the Journal: (JOURNAL) of March/25,/2021
- future: Studies are needed to understand the relationship among pancreatic exocrine enzyme imaging and anti-PD-1 diabetes.
SUMMARY
In this report, the authors present a patient with intrahepatic cholangiocarcinoma who had anti-PD-1-induced type 1 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.